Opens in a new tab

Dr. Zhou Daihan

Chinese name: 周岱翰
Chief Physician, Professor, Doctoral Supervisor, Chief Professor of Guangzhou University of Chinese Medicine . TCM Oncology
Professor Zhou Daihan is a National Master of Chinese Medicine, Director of the Oncology Research Institute of Guangzhou University of Chinese Medicine, and founding Director of Oncology at the First Affiliated Hospital. A leading TCM oncologist, he created the 'treating cancer with survival' concept and developed anti-tumour preparations such as He-Chan Pian.

Private & confidential

No obligation

Coordinated end-to-end by Orisene

over 50 years
Clinical practice in traditional Chinese medicine oncology
3rd cohort, 2017
National TCM Master (Guoyi Dashi) title conferred
1 approved new drug
First Chinese patent medicine for lung cancer developed (Hecan Pian)

  • The Physician

About Dr. Zhou Daihan

Professor Zhou Daihan is a National Master of Chinese Medicine, an academician-style expert of the China Academy of Chinese Medical Sciences, Director of the Oncology Research Institute of Guangzhou University of Chinese Medicine, and founding Director of Oncology at the First Affiliated Hospital. He has devoted his career to integrating traditional Chinese and Western medicine for advanced and refractory cancers, including lung, liver, colorectal and nasopharyngeal cancer, and cancer pain. He pioneered the 'treating cancer with survival' concept, founded the Lingnan TCM oncology academic school, and developed preparations such as He-Chan Pian. Chief editor of the textbook TCM Oncology, he has published ten representative works and received major national and provincial science awards.
1、Third National Master of Chinese Medicine
2、Member of the Academic Division of the China Academy of Chinese Medical Sciences
3、Director of the Oncology Research Institute of Guangzhou University of Chinese Medicine
4、Founding Director of Oncology at the First Affiliated Hospital
5、Creator of the ‘treating cancer with survival’ concept and founder of the Lingnan TCM oncology academic school
6、Recipient of the National Outstanding Contribution Award for Chinese Medicine (2019) and the State Council Special Allowance
7、Chief editor of the national textbook TCM Oncology

Dr. Zhou Daihan ’s Three Key Areas of Expertise

Three areas of focused expertise, each supported by a deep subspecialty team, high case volumes and an English-speaking care pathway coordinated by Orisene.

Advanced lung cancer

He diagnoses and treats advanced non-small-cell lung cancer with integrated Chinese and Western medicine, combining herbal formulae such as He-Chan Pian with chemotherapy and targeted therapy to control tumour growth, relieve symptoms and prolong survival for patients with late-stage lung cancer.

Liver and colorectal cancer

He treats primary liver cancer and colorectal cancer using syndrome-differentiation herbal therapy alongside conventional treatment, aiming to protect liver function, reduce treatment toxicity, enhance immune function and improve the quality of life of patients with these common digestive-system malignancies in clinical practice.

Nasopharyngeal cancer and cancer pain

He manages nasopharyngeal carcinoma and cancer-related pain with individualised herbal prescriptions and acupuncture, working to reduce radiotherapy side effects, control persistent pain, support nutrition and immunity and maintain the daily comfort of patients living with advanced or recurrent tumours in routine care.

More：lung cancer——TCM therapy; liver cancer——integrated care; colorectal cancer——herbal treatment; nasopharyngeal cancer——supportive care; cancer pain——management

  • Clinical Practice & Publications

Selected cases, research & publications

Representative work drawn from documented clinical treatments, publicly indexed literature, and hospital project records, reflecting the depth of this physician's hands-on expertise and academic rigor.
1. Hecan Pian for advanced lung cancer
Hecan Pian is a Chinese patent medicine developed by Professor Zhou Daihan for patients with lung cancer, combining herbal antitumor agents to relieve cough, reduce pleural effusion and improve quality of life. It became one of the earliest approved Chinese medicines for lung cancer and is still used alongside chemotherapy in advanced non-small cell lung cancer patients.
2. Survival-with-tumor strategy for advanced cancer
Professor Zhou Daihan pioneered the survival-with-tumor concept, guiding treatment of patients with advanced lung, liver and colorectal cancer who cannot be cured by surgery. Instead of eradicating every tumor cell, the strategy harmonizes vital qi and cancer toxins to control tumor growth, ease symptoms and prolong survival while improving quality of life.
3. Yiqi Chutan and Peitu Shengjin therapy for lung cancer
This clinical approach treats lung cancer by tonifying qi, resolving phlegm and strengthening the spleen and lung, targeting the deficiency-toxin pattern seen in most patients. Used in outpatient lung cancer care, it reduces chemotherapy side effects, improves immune function and quality of life, and is supported by research on the AKT signaling pathway in cisplatin-resistant lung cancer cells.
4. Shentao Ruangan Wan for primary liver cancer
Shentao Ruangan Wan is a hospital preparation created by Professor Zhou Daihan to treat patients with primary liver cancer, especially those with ascites or after transarterial chemoembolization. Combined with syndrome differentiation, it aims to soften the liver, disperse masses, support healthy qi and relieve abdominal distension, jaundice and poor appetite in advanced liver cancer patients.
5. Integrated research on Chinese herbal medicine and chemotherapy
Professor Zhou Daihan has led integrated Chinese and Western medicine antitumor research for decades, exploring how herbal formulas interact with chemotherapy and radiotherapy in cancer patients. His work on clearing heat, detoxifying and supporting vital qi helped build the evidence base for traditional Chinese medicine in advanced lung, liver and nasopharyngeal cancer treatment.
6. Clinical syndrome differentiation for advanced cancer patients
In his oncology clinic, Professor Zhou Daihan applies syndrome differentiation to treat patients with advanced cancer, tailoring herbal formulas to each person’s constitution and disease stage. This patient-centered approach focuses on controlling tumors, relieving pain and fatigue, and helping patients with lung, liver and colorectal cancer live longer with a better quality of life.
  • Affiliated Hospital

Where Dr. Zhou Daihan practices

Guangzhou

The First Affiliated Hospital of Guangzhou University of Chinese Medicine

Chinese name: 广州中医药大学第一附属医院
Founded in 1964, the First Affiliated Hospital of Guangzhou University of Chinese Medicine is one of China's first Grade-A tertiary TCM hospitals. With 2,200 beds and 3.19 million annual visits, it is renowned for TCM gastroenterology, orthopedics and gynecology, led by national masters of Chinese medicine.
62 years of TCM care
Since 1964
2,200
Licensed beds
3.19 million
Annual outpatient & emergency visits
7
Licensed beds
View Hospital Profile
Appointments with this physician are booked through official hospital channels only, coordinated end-to-end by Orisene.
  • WHY INTERNATIONAL PATIENTS CHOOSE CHINA

Why patients travel to China for treatment

Six reasons international patients now put China on their shortlist — from internationally aligned clinical capability to the policy channels that make treatment here genuinely reachable.

Clinical capability at international standard

Chinese hospitals deliver internationally aligned protocols, performing vast volumes of advanced robotic, minimally invasive, and complex transplant surgeries annually. This massive clinical data and highly specialized workforce ensure world-class outcomes, even for rare and complex cases.

Diagnostics and treatment in days, not months

A full medical workup that typically means months of waiting elsewhere is completed in China within 48–72 hours. Imaging, labs, and multidisciplinary consultations are integrated into a single visit, allowing treatment to commence immediately.

Transparent, itemised pricing

Chinese healthcare offers legally binding, itemised cost estimates before treatment begins, eliminating hidden fees or surprise billing. Due to national centralized procurement, total expenses remain 40–70% lower than comparable care in Western Europe or North America.

Policy channels that open the door

China facilitates access through 240-hour visa-free transit and dedicated medical visa routes. Policies like the Greater Bay Area drug pathway and Boao Lecheng’s pilot zone allow designated hospitals to administer innovative therapies not yet globally approved.
  • International Patient Guide

Consulting this physician, step by step

From the first message to the follow-up after you fly home, one coordinator, no paperwork on your side.
01
Day 0
  • Share your story
    A private consultation with an Orisene advisor, by message, phone or video. Send medical records in any language. Nothing is shared with the hospital yet.
02
Days 1–3
  • Records review & matching
    Orisene translates and presents your case to the right specialist. The hospital returns a tailored care plan, with costs itemised once that plan is confirmed.
03
Days 3–7
  • Your consultation
    Appointments are booked through official hospital channels only. Your navigator accompanies every visit with real-time interpretation, so you can focus on one thing: being cared for.
04
After you fly home
  • Reports & follow-up
    Translated reports and prescriptions delivered within days, remote follow-up coordination with your physicians at home, and a standing line to your navigator.
Orisene offers English and multilingual services, a professional medical interpreter at every consultation, plus translation of your records, reports and prescriptions.

Ready to plan your consultation with Dr. Zhou Daihan?

Send your records in any language. An Orisene advisor will reply within 2 hours, present your case to the right specialist, and return a tailored care plan with itemised costs, before anything is booked. Simple. Private. Efficient.
Contact

Confidential, permanently

Independent — no hospital commission

We never handle medical fees

Information Sources

This physician profile is compiled by the Orisene team from publicly available online sources and verified at the time of publication. Details may change, and physician availability is confirmed at the time of booking.

Disclaimer: This information is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personal medical guidance.

Mention of any specific product, brand, or manufacturer is for informational purposes only and does not constitute an endorsement or recommendation by Dr. Zhou Daihan.